Persistent URL of this record https://hdl.handle.net/1887/3279845
Documents
-
- Download
- 17588359211033704
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
- All authors
- Sijde, F. van der; Azmani, Z.; Besselink, M.G.; Bonsing, B.A.; Groot, J.W.B. de; Koerkamp, B.G.; Haberkorn, B.C.M.; Homs, M.Y.V.; IJcken, W.F.J. van; Janssen, Q.P.; Lolkema, M.P.; Luelmo, S.A.C.; Mekenkamp, L.J.M.; Mustafa, D.A.M.; Schaik, R.H.N. van; Wilmink, J.W.; Vietsch, E.E.; Eijck, C.H.J. van
- Date
- 2021-08-01
- Volume
- 13
- Pages
- 1 - 14